文献速递临床试验与 GCP

G-FORCE:团体心理治疗对C类人格障碍的有效性:一项比较心理动力性与两种图式团体治疗的实用性随机对照试验方案

G-FORCE: the effectiveness of group psychotherapy for Cluster-C personality disorders: protocol of a pragmatic RCT comparing psychodynamic and two forms of schema group therapy.
PubMed 文献 · Trials · 2023-04-29

本研究为单中心实用性随机对照试验,计划纳入290例C类人格障碍或具有 predominantly C类特质的其他特定人格障碍患者,随机分配至C类图式团体治疗(GST-C,1年)、图式聚焦团体治疗(SFGT,1.5年)或心理动力性团体治疗(PG,2年)。主要结局为24个月内人格障碍严重程度(APD-IV)的变化,同时评估成本效果、预测因素与中介因素。

要点

  • 首个针对C类人格障碍团体心理治疗的大型随机对照试验,比较三种团体治疗形式的(成本)效果。
  • 主要结局为24个月内人格障碍严重程度(APD-IV)变化,随机化按人格障碍类型预分层。
  • 研究同时分析预测因素、过程与流程变量,以探究治疗起效机制。

核心结论

  • 本研究旨在评估三种团体心理治疗形式对C类人格障碍的有效性和成本效果,并分析预测因素、过程与流程变量以探究治疗起效机制。
  • 这是首个针对C类人格障碍团体治疗的大型随机对照试验,将有助于改善这一被忽视患者群体的照护。

研究设计与样本

  • 单中心实用性随机对照试验,计划纳入290例C类人格障碍或其他以C类特质为主的特定人格障碍患者。
  • 随机分配至三组:C类图式团体治疗(GST-C,1年)、图式聚焦团体治疗(SFGT,1.5年)或心理动力性团体治疗(PG,2年),随机化按人格障碍类型预分层。
  • 评估时间点为基线、治疗开始及治疗后1、3、6、9、12、18、24和36个月。

关键数值与推荐

  • 主要结局指标为24个月内人格障碍严重程度(APD-IV)的变化。
  • 次要结局指标包括人格功能、精神症状和生活质量。
  • 将基于社会视角开展成本效果研究,同时使用临床效果和质量调整生命年。

局限性

  • 原文指出缺乏对照组可被视为一项局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cluster-C personality disorders (PDs), characterized by a high level of fear and anxiety, are related to high levels of distress, societal dysfunctioning and chronicity of various mental health disorders. Evidence for the optimal treatment is extremely scarce. Nevertheless, the need to treat these patients is eminent. In clinical practice, group therapy is one of the frequently offered approaches, with two important frameworks: schema therapy and psychodynamic therapy. These two frameworks suggest different mechanisms of change, but until now, this has not yet been explored. The purpose of the present G-FORCE trial is to find evidence on the differential (cost)effectiveness of two forms of schema group therapy and psychodynamic group therapy in the routine clinical setting of an outpatient clinic and to investigate the underlying working mechanisms and predictors of outcome of these therapies. METHODS: In this mono-centre pragmatic randomized clinical trial, 290 patients with Cluster-C PDs or other specified PD with predominantly Cluster-C traits, will be randomized to one of three treatment conditions: group schema therapy for Cluster-C (GST-C, 1 year), schema-focused group therapy (SFGT, 1.5 year) or psychodynamic group therapy (PG, 2 years). Randomization will be pre-stratified on the type of PD. Change in severity of PD (APD-IV) over 24 months will be the primary outcome measure. Secondary outcome measures are personality functioning, psychiatric symptoms and quality of life. Potential predictors and mediators are selected and measured repeatedly. Also, a cost-effectiveness study will be performed, primarily based on a societal perspective, using both clinical effects and quality-adjusted life years. The time-points of assessment are at baseline, start of treatment and after 1, 3, 6, 9, 12, 18, 24 and 36 months. DISCUSSION: This study is designed to evaluate the effectiveness and cost-effectiveness of three formats of group psychotherapy for Cluster-C PDs. Additionally, predictors, procedure and process variables are analysed to investigate the working mechanisms of the therapies. This is the first large RCT on group therapy for Cluster-C PDs and will contribute improving the care of this neglected patient group. The absence of a control group can be considered as a limitation. TRIAL REGISTRATION: CCMO, NL72826.029.20 . Registered on 31 August 2020, first participant included on 18 October 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van den Heuvel BB, Dekker JJM, Daniëls M, et al. G-FORCE: the effectiveness of group psychotherapy for Cluster-C personality disorders: protocol of a pragmatic RCT comparing psychodynamic and two forms of schema group therapy. Trials. 2023. PMID: 37120550. doi:10.1186/s13063-023-07309-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。